RESMED INC — Director's Dealing 2016

Oct 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-10-17

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-17	ResMed Common Stock	M	5975	$33.70	Acquired	203781	Direct
2016-10-17	ResMed Common Stock	S	5975	$64.246	Disposed	197806	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-17	ResMed Common Stock Options	$33.70	M	5975	Disposed	2017-11-11	ResMed Commmon Stock (5975)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: This transaction was executed in multiple trades at prices ranging from $64.15 to $64.43. The price reported above reflects the weighted average sale price.

F3: Represents date options first became exercisable. Options vest 1/4 per year.